International price comparisons for novel and follow-on drugs

Value in Health

Volumn 10, Issue 6, 2007, Pages 510-511

  Ridley, David B ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ONDANSETRON; SUMATRIPTAN;

DRUG COST; DRUG MANUFACTURE; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HEALTH CENTER; PRIORITY JOURNAL;

AUSTRALIA; COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; INTERNATIONALITY; NATIONAL HEALTH PROGRAMS; RATE SETTING AND REVIEW; UNITED STATES;

EID: 35549010585     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00238.x     Document Type: Editorial

References (14)

1. IMS Health. Global pharmaceutical sales by region, 2006. Available from: http://www.imshealth.com/ims/portal/front/articleC/0,2777, 6599_80528184_80528215,00.html [Accessed June 8, 2007].
2. Olson M, Zeckhauser R. An economic theory of alliances. Rev Econ Stat 1965 47 : 266 79.
3. McClellan M. Remarks before the First International Colloquium on Generic Medicine. Cancun, Mexico, September 25, 2003. Available from: http://www.fda.gov/oc/speeches/2003/genericdrug0925.html [Accessed May 31, 2007].
4. Danzon P, Wang YR, Wang L. The impact of price regulation on the launch delay of new drugs. Health Econ 2005 14 : 269 92.
5. Kyle MK. Pharmaceutical price controls and entry strategies. Rev Econ Stat 2007 89 : 88 99.
6. Dugger CW. Brazil overrides Merck patent on AIDS drug. The New York Times. May 5, 2007 Available from: http://www.nytimes.com/2007/05/05/world/ americas/05briefs-brazil.html [Accessed May 31, 2007].
7. Roughead EE, Lopert R, Sansom LN. Prices for innovative pharmaceutical products that provide health gain: a comparison between Australia and USA. Value Health 2007 doi: 10.1111/j.1524-4733.2007.00206.x.
8. Calfee JE, Villarreal M, DuPré E. An exploratory analysis of pharmaceutical price disparities and their implications among six developed nations. Working Paper 06-07. April 2006.
9. Ridley DB. Payments, promotion, and the purple pill. Duke University working paper. 2006.
10. Centers for Medicare and Medicaid Services. Available from: http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice [Accessed May 31, 2007].
11. Ridley DB. Price differentiation and transparency in the global pharmaceutical marketplace. Pharmacoeconomics 2005 23 : 651 8.
12. Kyle MK, Ridley DB. Would greater price transparency and uniformity benefit poor patients? Health Aff (in press).
13. Grabowski HG, Ridley DB, Schulman KA. Entry and competition in generic biologicals. Managerial and Decision Economics (in press).
14. Danzon PM, Furukawa MF. Prices and availability of pharmaceuticals: evidence from nine countries. Health Affairs Web Exclusive. October 29, 2003. Available from: http://content.healthaffairs.org/cgi/content/abstract/hlthaff. w3.521v1 [Accessed May 31, 2007].